Abstract Ziyuglycoside II (ZGS II) is a major bioactive ingredient of Sanguisorbae officinalis
L., which has been widely used for managing myelosuppression or leukopenia induced by …

Radix Sanguisorbae, the root of Sanguisorba officinalis L. is used as traditional Chinese
medicine. In recent decades, it has been reported to be clinically effective against …

Background and purpose Osteoporosis (OP) is a frequent clinical problem for the elderly.
Traditional Chinese Medicine (TCM) has achieved beneficial results in the treatment of OP …

Abstract Ethnopharmacological relevance Yiqi Shengsui formula (YQSSF) is a commonly
used formula to treat chemotherapy-induced myelosuppression, but little is known about its …

What is known and objective We have previously shown that the saponins of Sanguisorba
parviflora (Maxim.) Takeda (Sp. T) relieved cyclophosphamide‐induced myelosuppression …

Digestive system cancers, including liver, gastric, colon, esophageal and pancreatic
cancers, are the leading cause of cancers with high morbidity and mortality, and the …

Protective effects and mechanism of total saponins of Sanguisorba officinalis L.(TSSO) on
myelosuppressivemiceinduced by 60 Co-γ ray was investigated. The myelosuppressivemice …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide.
Phytochemicals are important candidates for developing anticancer agents. Ziyuglycoside II …

Objective: This study aimed to investigate the therapeutic effect of Specnuezhenide on
myelosuppression induced by chemotherapy and clarify its mechanism. Methods: In this …

Ziyuglycoside II is one of the major active compounds of Sanguisorba officinalis L., which
has a wide range of clinical applications including hemostasis, antibiosis, anti-inflammation …